212 related articles for article (PubMed ID: 10201649)
1. Relation of dehydroepiandrosterone and dehydroepiandrosterone sulfate with cardiovascular disease risk factors in women: longitudinal results from the Massachusetts Women's Health Study.
Johannes CB; Stellato RK; Feldman HA; Longcope C; McKinlay JB
J Clin Epidemiol; 1999 Feb; 52(2):95-103. PubMed ID: 10201649
[TBL] [Abstract][Full Text] [Related]
2. Dehydroepiandrosterone, dehydroepiandrosterone sulphate and cardiovascular disease.
Khaw KT
J Endocrinol; 1996 Sep; 150 Suppl():S149-53. PubMed ID: 8943798
[TBL] [Abstract][Full Text] [Related]
3. Serum dehydroepiandrosterone levels are associated with lower risk of type 2 diabetes: the Rotterdam Study.
Brahimaj A; Muka T; Kavousi M; Laven JS; Dehghan A; Franco OH
Diabetologia; 2017 Jan; 60(1):98-106. PubMed ID: 27771738
[TBL] [Abstract][Full Text] [Related]
4. Serum DHEA and Its Sulfate Are Associated With Incident Fall Risk in Older Men: The MrOS Sweden Study.
Ohlsson C; Nethander M; Karlsson MK; Rosengren BE; Ribom E; Mellström D; Vandenput L
J Bone Miner Res; 2018 Jul; 33(7):1227-1232. PubMed ID: 29528519
[TBL] [Abstract][Full Text] [Related]
5. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR
Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
[TBL] [Abstract][Full Text] [Related]
6. Low dehydroepiandrosterone sulfate and heart disease in middle-aged men: cross-sectional results from the Massachusetts Male Aging Study.
Feldman HA; Johannes CB; McKinlay JB; Longcope C
Ann Epidemiol; 1998 May; 8(4):217-28. PubMed ID: 9590600
[TBL] [Abstract][Full Text] [Related]
7. A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease.
Barrett-Connor E; Khaw KT; Yen SS
N Engl J Med; 1986 Dec; 315(24):1519-24. PubMed ID: 2946952
[TBL] [Abstract][Full Text] [Related]
8. Cortisol, dehydroepiandrosterone (DHEA), and DHEA sulfate in the cerebrospinal fluid of man: relation to blood levels and the effects of age.
Guazzo EP; Kirkpatrick PJ; Goodyer IM; Shiers HM; Herbert J
J Clin Endocrinol Metab; 1996 Nov; 81(11):3951-60. PubMed ID: 8923843
[TBL] [Abstract][Full Text] [Related]
9. Effects of transdermal application of DHEA on the levels of steroids, gonadotropins and lipids in men.
Sulcová J; Hill M; Hampl R; Masek Z; Novácek A; Ceska R; Stárka L
Physiol Res; 2000; 49(6):685-93. PubMed ID: 11252535
[TBL] [Abstract][Full Text] [Related]
10. Sex-specific association of serum dehydroepiandrosterone and its sulfate levels with osteoporosis in type 2 diabetes.
Li S; Li W; Chang L; Wan J; Chen S; Zhang X; He Q; Liu M
J Bone Miner Metab; 2024 May; 42(3):361-371. PubMed ID: 38769209
[TBL] [Abstract][Full Text] [Related]
11. Low Serum Dehydroepiandrosterone and Dehydroepiandrosterone Sulfate Are Associated With Coronary Heart Disease in Men With Type 2 Diabetes Mellitus.
Zhang X; Xiao J; Liu T; He Q; Cui J; Tang S; Li X; Liu M
Front Endocrinol (Lausanne); 2022; 13():890029. PubMed ID: 35832423
[TBL] [Abstract][Full Text] [Related]
12. Sexual dimorphism in the influence of advanced aging on adrenal hormone levels: the Rancho Bernardo Study.
Laughlin GA; Barrett-Connor E
J Clin Endocrinol Metab; 2000 Oct; 85(10):3561-8. PubMed ID: 11061502
[TBL] [Abstract][Full Text] [Related]
13. Low dehydroepiandrosterone and ischemic heart disease in middle-aged men: prospective results from the Massachusetts Male Aging Study.
Feldman HA; Johannes CB; Araujo AB; Mohr BA; Longcope C; McKinlay JB
Am J Epidemiol; 2001 Jan; 153(1):79-89. PubMed ID: 11159150
[TBL] [Abstract][Full Text] [Related]
14. Low serum levels of dehydroepiandrosterone sulfate predict all-cause and cardiovascular mortality in elderly Swedish men.
Ohlsson C; Labrie F; Barrett-Connor E; Karlsson MK; Ljunggren O; Vandenput L; Mellström D; Tivesten A
J Clin Endocrinol Metab; 2010 Sep; 95(9):4406-14. PubMed ID: 20610590
[TBL] [Abstract][Full Text] [Related]
15. DHEA, DHEAS and PCOS.
Goodarzi MO; Carmina E; Azziz R
J Steroid Biochem Mol Biol; 2015 Jan; 145():213-25. PubMed ID: 25008465
[TBL] [Abstract][Full Text] [Related]
16. Dehydroepiandrosterone sulfate does not predict cardiovascular death in postmenopausal women. The Rancho Bernardo Study.
Barrett-Connor E; Goodman-Gruen D
Circulation; 1995 Mar; 91(6):1757-60. PubMed ID: 7882484
[TBL] [Abstract][Full Text] [Related]
17. Relationship of serum dehydroepiandrosterone (DHEA), DHEA sulfate, and 5-androstene-3 beta, 17 beta-diol to risk of breast cancer in postmenopausal women.
Dorgan JF; Stanczyk FZ; Longcope C; Stephenson HE; Chang L; Miller R; Franz C; Falk RT; Kahle L
Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):177-81. PubMed ID: 9138660
[TBL] [Abstract][Full Text] [Related]
18. The association of plasma DHEA and DHEA sulfate with breast cancer risk in predominantly premenopausal women.
Tworoger SS; Missmer SA; Eliassen AH; Spiegelman D; Folkerd E; Dowsett M; Barbieri RL; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):967-71. PubMed ID: 16702378
[TBL] [Abstract][Full Text] [Related]
19. Serum dehydroepiandrosterone and dehydroepiandrosterone sulfate and the subsequent risk of developing colon cancer.
Alberg AJ; Gordon GB; Hoffman SC; Comstock GW; Helzlsouer KJ
Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):517-21. PubMed ID: 10815698
[TBL] [Abstract][Full Text] [Related]
20. Biotransformation of oral dehydroepiandrosterone in elderly men: significant increase in circulating estrogens.
Arlt W; Haas J; Callies F; Reincke M; Hübler D; Oettel M; Ernst M; Schulte HM; Allolio B
J Clin Endocrinol Metab; 1999 Jun; 84(6):2170-6. PubMed ID: 10372727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
